Published in Pneumonol Alergol Pol on January 01, 2013
B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review. BMC Pulm Med (2017) 0.75
Elevated TGF-beta1 concentration in bronchoalveolar lavage fluid from patients with primary lung cancer. Arch Immunol Ther Exp (Warsz) (2006) 0.99
The cellular composition and macrophage phenotype in induced sputum in smokers and ex-smokers with COPD. Chest (2003) 0.95
Cardiac involvement in Wegener's granulomatosis resistant to induction therapy. Eur Radiol (2011) 0.92
Bronchoalveolar lavage total cell count in interstitial lung diseases--does it matter? Inflammation (2012) 0.91
Acute respiratory failure in a patient with spontaneous esophageal rupture (Boerhaave syndrome). Respir Care (2011) 0.89
[Hemorrhagic parapneumonic effusion in a 64 year-old patient as the first symptom of hemophilia B]. Pneumonol Alergol Pol (2009) 0.88
Noncorticosteroid immunosuppression limits myocardial damage and contractile dysfunction in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). J Am Coll Cardiol (2015) 0.86
Increased proportion of Fas positive CD8+ cells in peripheral blood of patients with COPD. Respir Med (2006) 0.86
Comparing supplementary oxygen benefits from a portable oxygen concentrator and a liquid oxygen portable device during a walk test in COPD patients on long-term oxygen therapy. Respir Med (2008) 0.82
Obstructive sleep apnea in shift workers. Sleep Med (2011) 0.82
[The influence of 3 weeks therapy with continuous positive airway pressure on serum leptin and homocysteine concentration in patients with obstructive sleep apnea syndrome]. Pneumonol Alergol Pol (2006) 0.81
Airway dimensions in asthma and COPD in high resolution computed tomography: can we see the difference? Respir Care (2013) 0.81
[Effects of nurse home visits on compliance to long-term oxygen therapy. 14 months follow-up]. Pneumonol Alergol Pol (2009) 0.81
Diagnosis and management of premature ventricular complexes-associated chronic cough. Chest (2009) 0.80
Continuous positive airway pressure treatment increases bronchial reactivity in obstructive sleep apnea patients. Respiration (2009) 0.80
[Real-time PCR assay for detection and quantification of human adenoviruses in patients with haematological malignancies and symptoms of lower respiratory tract infection]. Przegl Epidemiol (2011) 0.80
The value of cytological diagnosis of small cell lung carcinoma. Pneumonol Alergol Pol (2010) 0.80
[Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer]. Pol Arch Med Wewn (2004) 0.80
Expression of eotaxins in the material from nasal brushing in asthma, allergic rhinitis and COPD patients. Cytokine (2012) 0.79
[Exhaled nitric oxide in patients with obstructive sleep apnea syndrome]. Pneumonol Alergol Pol (2006) 0.79
[Diagnosis of tuberculous lymphadenitis based on the fine needle aspiration samples analysis]. Pneumonol Alergol Pol (2006) 0.79
[Mortality and comorbidity in hospitalized chronic obstructive pulmonary disease patients]. Pneumonol Alergol Pol (2011) 0.79
[Lymphocyte and lymphocyte subsets in pleural fluid--comparison of malignant and non-malignant disorders]. Pol Arch Med Wewn (2004) 0.79
[Three month continuous positive airway pressure (CPAP) therapy decreases serum total and LDL cholesterol, but not homocysteine and leptin concentration in patients with obstructive sleep apnea syndrome (OSAS)]. Pneumonol Alergol Pol (2011) 0.78
[Diagnostic utility of the molecular assay GenoType MTBC (HAIN Lifesciences, Germany) for identification of tuberculous mycobacteria]. Pneumonol Alergol Pol (2009) 0.78
Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg-Strauss syndrome and granulomatosis with polyangiitis (Wegener's) in patients with normal electrocardiograms and transthoracic echocardiography. Int J Cardiovasc Imaging (2012) 0.78
[Factors influencing asthma course and the degree of control in the patients assessed with own questionnaire and Asthma Control Test (ACT)]. Pneumonol Alergol Pol (2012) 0.78
[The relationship between markers of airway inflammation and thickness of the basement membrane in patients with asthma]. Pneumonol Alergol Pol (2007) 0.78
[The effect of asthma and COPD exacerbation on exhaled nitric oxide (FE(NO))]. Pneumonol Alergol Pol (2004) 0.78
[Is microembolism present and is it important element of COPD exacerbation?]. Pol Merkur Lekarski (2005) 0.78
[Analysis of solitary pulmonary nodules found in chest radiograms]. Pneumonol Alergol Pol (2009) 0.77
Correlation between hyperinflation defined as an elevated RV/TLC ratio and body composition and cytokine profile in patients with chronic obstructive pulmonary disease. Pneumonol Alergol Pol (2015) 0.77
Effect of exacerbation frequency on body composition and serum ghrelin and adiponectin concentrations in patients with chronic obstructive pulmonary disease. Pol Arch Med Wewn (2014) 0.77
[The influence of gastroesophageal reflux on asthma]. Wiad Lek (2002) 0.77
Simplified method of dynamic contrast-enhanced computed tomography in the evaluation of indeterminate pulmonary nodules. Respiration (2009) 0.77
Pleural Effusion in Meigs' Syndrome-Transudate or Exudate?: Systematic Review of the Literature. Medicine (Baltimore) (2015) 0.77
[Relationship between airway basement membrane thickness and lung function tests in patients with asthma]. Pneumonol Alergol Pol (2009) 0.77
Serum levels of apoptosis-related markers (sFasL, TNF-a, p53 and bcl-2) in COPD patients. Pneumonol Alergol Pol (2015) 0.76
[The role of viruses in the pathogenesis of obstructive lung diseases]. Pol Merkur Lekarski (2003) 0.76
[Serum leptin concentration and sympathetic activation estimated on the adrenaline and noradrenaline serum concentration in patients with obstructive sleep apnea]. Pol Arch Med Wewn (2005) 0.76
The expression of the eotaxins IL-6 and CXCL8 in human epithelial cells from various levels of the respiratory tract. Cell Mol Biol Lett (2013) 0.76
[Serum concentration of homocysteine and the risk of atherosclerosis in patients with obstructive sleep apnea syndrome]. Pneumonol Alergol Pol (2006) 0.76
Prevalence of metabolic syndrome diagnosis in patients with obstructive sleep apnoea syndrome according to adopted definition. Pneumonol Alergol Pol (2013) 0.76
[Role of eotaxin in the pathophysiology of asthma]. Pneumonol Alergol Pol (2007) 0.76
[Sarcoidal reaction in lung adenocarcinoma in 50-years old man]. Pneumonol Alergol Pol (2010) 0.75
[Influence of bronchoscopy on nitric oxide in exhaled air]. Pneumonol Alergol Pol (2006) 0.75
[Influence of inhaler and fine particle on efficacy of inhalation therapy in COPD]. Pneumonol Alergol Pol (2014) 0.75
[Diagnostic utility of pleural fluid eosinophilia]. Pneumonol Alergol Pol (2006) 0.75
[Estimation of volume of pleural fluid and its impact on spirometrical parameters]. Pol Merkur Lekarski (2014) 0.75
[Tracheobronchopathia osteochondroplastica]. Pneumonol Alergol Pol (2002) 0.75
[Lung cancer in COPD--a clinical analysis]. Pol Arch Med Wewn (2002) 0.75
MRI-based evidence for myocardial involvement in women with hypereosinophilic syndrome. Magn Reson Med Sci (2015) 0.75
[Familial clustering of symptoms typical for OSAS]. Pneumonol Alergol Pol (2006) 0.75
[Capsaicin inhalation cough challenge in an evaluation of cough threshold--preliminary study]. Pol Merkur Lekarski (2014) 0.75
Quantitative myocardial contrast supine bicycle stress echocardiography for detection of coronary artery disease. Echocardiography (2012) 0.75
[Functional nasal surgery in the treatment of obstructive sleep apnea]. Pneumonol Alergol Pol (2004) 0.75
[Viral infections as exacerbation factor of obstructive pulmonary disease--COPD and asthma. Prevention, diagnostic and therapy problems]. Pol Arch Med Wewn (2003) 0.75
[Genetic predisposition to ischemic heart disease in patients with obstructive sleep apnea syndrome (OSAS)]. Pol Merkur Lekarski (2014) 0.75
[Maximal respiratory pressures and exercise tolerance in patients with COPD]. Pneumonol Alergol Pol (2006) 0.75
Hemoptysis in a patient with multifocal primary pulmonary angiosarcoma. Pneumonol Alergol Pol (2016) 0.75
Heterozygous α1‑antitrypsin deficiency in liver transplant candidates. Pol Arch Med Wewn (2012) 0.75
Leflunomide-induced acute interstitial pneumonia in a patient treated for rheumatoid arthritis. Pneumonol Alergol Pol (2015) 0.75
[Asthma-induced myocardial infarction in a 39-year-old woman]. Pol Merkur Lekarski (2003) 0.75
[Holter ECG monitoring during research bronchofiberoscopy in patients with asthma]. Pneumonol Alergol Pol (2006) 0.75
[Clinical effects of surgical treatment of obstructive sleep apnea syndrome]. Pol Arch Med Wewn (2002) 0.75
[Non-invasive ventilation in Poland in 2012]. Pneumonol Alergol Pol (2012) 0.75
[Correlation between bronchoscopically visible aspects and histopathologic results in patients with suspected lung cancer]. Pol Arch Med Wewn (2002) 0.75
Left brachiocephalic vein stenosis and infectious aortitis: two unusual causes of Ortner's syndrome. Pneumonol Alergol Pol (2015) 0.75
PDE4 inhibitors have no effect on eotaxin expression in human primary bronchial epithelial cells. Acta Biochim Pol (2012) 0.75
[Reproducibility of exhaled nitric oxide (FENO) measurements in healthy subjects]. Pneumonol Alergol Pol (2004) 0.75
Cardiac involvement in hypereosinophilic syndrome. Pol Arch Med Wewn (2013) 0.75
[The interpretation of carbon monoxide diffusing capacity test depending of hemoglobin concentration]. Pneumonol Alergol Pol (2006) 0.75
[Radial segmentation of lymphocytes in peripheral blood of patients with non-small cell lung cancer ]. Wiad Lek (2002) 0.75
Methods of airway resistance assessment. Pneumonol Alergol Pol (2016) 0.75
Treatment with continuous positive airway pressure and diurnal and nocturnal serum melatonin concentration in patients with obstructive sleep apnea. Pol Arch Intern Med (2017) 0.75
[Sarcoidosis and tobacco smoking--clinical picture, diagnostic tests results and bronchoalveolar lavage fluid composition]. Pol Merkur Lekarski (2012) 0.75
[Mycolic acids analysis from various species mycobacterium by high pressure liquid chromatography (HPLC)]. Pneumonol Alergol Pol (2002) 0.75
[GOLD 2011 - COPD from a new perspective]. Pol Merkur Lekarski (2013) 0.75
Comparison of airway wall remodeling in asthma and COPD: biopsy findings. Respir Care (2011) 0.75
Computed tomography characteristics of coronary artery atherosclerosis in subjects with lower extremity peripheral artery disease and no cardiac symptoms. Pol Arch Med Wewn (2013) 0.75
The utility of oesophageal pH monitoring in diagnosing gastroesophageal reflux disease-related chronic cough. Pneumonol Alergol Pol (2014) 0.75
[Bronchorrhea in a case of pneumonic type of bronchioloalveolar carcinoma]. Pol Arch Med Wewn (2004) 0.75
[Usefulness of selected tests in the diagnosis of exercise induced bronchoconstriction]. Pneumonol Alergol Pol (2011) 0.75